3/15
01:05 am
atyr
Medium
Report
3/12
03:33 pm
atyr
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting [Yahoo! Finance]
Low
Report
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting [Yahoo! Finance]
3/6
02:09 pm
atyr
aTyr Pharma (ATYR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
aTyr Pharma (ATYR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/5
04:31 pm
atyr
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update [Yahoo! Finance]
3/5
04:01 pm
atyr
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Medium
Report
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
2/20
04:01 pm
atyr
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/18
08:23 am
atyr
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
Medium
Report
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
2/18
08:00 am
atyr
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
Low
Report
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
2/3
08:00 am
atyr
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Medium
Report
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
1/11
07:40 pm
atyr
Is aTyr Pharma (NASDAQ:ATYR) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Medium
Report
Is aTyr Pharma (NASDAQ:ATYR) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]